Abrysvo is now approved in the EU for adults aged 18 to 59 who are at increased risk of lower respiratory tract disease ...

In this role, Dorelle will drive the agency’s strategic expansion, strengthen its market position, and spearhead its next ...

In this role, Kulkarni will drive the agency’s strategic expansion, strengthen its market position, and spearhead its next ...

Pharma stocks just got a new risk factorand it's not a new drug trial. President Trump is preparing to slap tariffs on ...

In this role, Kulkarni will drive the agency’s strategic expansion, strengthen its market position, and spearhead its next ...

Multinational corporations are expanding the availability of drugs in the hospital segment in anticipation of growing demand ...

Major drugmakers were trading sharply lower on Tuesday as Wall Street is bracing for a broader set of tariffs that President ...

A long-running struggle in Nigeria against fake medicines has become even harder because widespread economic hardship is driving up demand, experts say.

Long-standing trade agreements have largely sheltered the pharmaceutical industry from tariffs but President Donald Trump's ...

Highlighted with 90 tables and 69 figures, this 168-page report ?Asia Pacific Pharmaceutical Manufacturing Industry 2022-2032 by Formulation, Route of Administration, Consumer Group, Therapeutic ...

Highlighted with 93 tables and 69 figures, this 168-page report ?Europe Pharmaceutical Manufacturing Industry 2022-2032 by Formulation, Route of Administration, Consumer Group, Therapeutic Application ...